Veterinary Medicines Information website

TAbic M.B., šnypščiosios tabletės

Authorised
  • Infectious bursal disease virus, strain M.B., Live
Download as PDF

Product identification

Medicine name:
TAbic M.B., šnypščiosios tabletės
Active substance:
  • Infectious bursal disease virus, strain M.B., Live
Target species:
  • Chicken
Route of administration:
  • In drinking water use
  • Ocular use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain M.B., Live
    316.23
    50% Embryo Infective Dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Effervescent tablet
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken
      • Meat and offal
        0
        day
  • Ocular use
    • Chicken
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD09
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Available in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Phibro Animal Health (Poland) Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Synoptis Industrial Sp. z o.o.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/04/1611/001-007
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Lithuanian (PDF)
Published on: 15/01/2026
Download